NASDAQ:CELZ Creative Medical Technology (CELZ) Stock Price, News & Analysis $0.68 -0.04 (-5.78%) Closing price 10/29/2026 03:59 PM EasternExtended Trading$0.70 +0.02 (+2.74%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and TrendsOwnershipSEC Filings About Creative Medical Technology Stock (NASDAQ:CELZ) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CELZ alerts:Sign Up Key Stats Today's Range$0.68▼$0.7450-Day Range$0.68▼$1.3152-Week Range$0.62▼$4.72Volume62,555 shsAverage Volume107,680 shsMarket Capitalization$4.47 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Creative Medical Technology Holdings, Inc. is a biotechnology company focused on developing regenerative medicine and cellular therapies. Its research programs are designed to use stem cells and other biological approaches to address conditions for which existing treatment options may be limited. The company has developed and investigated therapies based on autologous stem cells, meaning cells collected from and administered back to the same patient. Its programs have included CaverStem, a regenerative treatment candidate for erectile dysfunction, as well as investigational platforms such as FemCelz for female sexual dysfunction and ImmCelz, an immune-modulating cellular therapy platform. These programs remain subject to clinical development and regulatory requirements. Creative Medical Technology Holdings has historically operated from the United States and has focused primarily on research, development and potential commercialization of regenerative medicine products rather than a broad portfolio of marketed pharmaceuticals. The company’s programs and corporate activities have evolved over time, and the availability or development status of individual candidates may change as clinical and regulatory work progresses.AI Generated. May Contain Errors. Read More Creative Medical Technology Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks34th Percentile Overall ScoreCELZ MarketRank™: 1.69174883238 of 5 starsCreative Medical Technology scored higher than 34% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.4 / 5Analyst RatingHold Consensus RatingCreative Medical Technology has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Amount of Analyst CoverageCreative Medical Technology has only been the subject of 2 research reports in the past 90 days.Read more about Creative Medical Technology's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Creative Medical Technology are expected to grow in the coming year, from ($1.18) to ($0.88) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Creative Medical Technology is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Creative Medical Technology is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCreative Medical Technology has a P/B Ratio of 0.33. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Creative Medical Technology's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.26% of the float of Creative Medical Technology has been sold short.Short Interest Ratio / Days to CoverCreative Medical Technology has a short interest ratio ("days to cover") of 0.87, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Creative Medical Technology has recently decreased by 50.21%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCreative Medical Technology does not currently pay a dividend.Dividend GrowthCreative Medical Technology does not have a long track record of dividend growth. News and Social Media2.9 / 5News Sentiment0.70 News SentimentCreative Medical Technology has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Creative Medical Technology this week, compared to 2 articles on an average week.MarketBeat Follows1 people have added Creative Medical Technology to their MarketBeat watchlist in the last 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Creative Medical Technology insiders have not sold or bought any company stock.Percentage Held by Insiders1.00% of the stock of Creative Medical Technology is held by insiders.Percentage Held by Institutions1.42% of the stock of Creative Medical Technology is held by institutions.Read more about Creative Medical Technology's insider trading history. Receive CELZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Creative Medical Technology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CELZ Stock News HeadlinesCreative Medical Technology (CELZ) Set to Announce Earnings on Friday3 hours ago | americanbankingnews.comReviewing Exicure (NASDAQ:XCUR) & Creative Medical Technology (NASDAQ:CELZ)October 26, 2026 | americanbankingnews.comTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery. | Behind the Markets (Ad)Creative Medical Technology Holdings, Inc. Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome Knee Osteoarthritis StudyOctober 22, 2026 | marketscreener.comMCreative Medical Reports 93% Response Rate In Ultrasome Knee Osteoarthritis Pilot StudyOctober 20, 2026 | rttnews.comCreative Medical Technology Holdings Highlights Positive Ultrasome™ Pilot Data in Knee Osteoarthritis StudyOctober 20, 2026 | quiverquant.comQCreative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis StudyOctober 20, 2026 | globenewswire.comCreative Medical Technology Expands Control of BioDefense SubsidiarySeptember 25, 2026 | tipranks.comSee More Headlines CELZ Stock Analysis - Frequently Asked Questions How have CELZ shares performed this year? Creative Medical Technology's stock was trading at $1.96 at the start of the year. Since then, CELZ shares have decreased by 65.4% and is now trading at $0.6784. How were Creative Medical Technology's earnings last quarter? Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) issued its quarterly earnings data on Friday, August, 7th. The company reported ($0.41) earnings per share for the quarter, missing analysts' consensus estimates of ($0.39) by $0.02. When did Creative Medical Technology's stock split? Creative Medical Technology shares reverse split on the morning of Sunday, June 11th 2023.The 1-10 reverse split was announced on Sunday, June 11th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, June 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Creative Medical Technology? Shares of CELZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Creative Medical Technology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Creative Medical Technology investors own include PayPal (PYPL), SNDL (SNDL), Tesla (TSLA), AMC Entertainment (AMC), FuelCell Energy (FCEL), Intel (INTC) and Bionano Genomics (BNGO). Company Calendar Last Earnings8/07/2026Today10/30/2026Next Earnings (Estimated)11/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 2 weeks, CELZ's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:CELZ CIK1187953 Webwww.creativemedicaltechnology.com Phone(480) 399-2822FaxN/AEmployees4Year Founded2008Profitability EPS (Trailing Twelve Months)($2.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$5.99 million Net MarginsN/A Pretax Margin-201,300.02% Return on Equity-86.52% Return on Assets-81.96% Debt Debt-to-Equity RatioN/A Current Ratio12.90 Quick Ratio12.90 Sales & Book Value Annual Sales$3 thousand Price / Sales1,490.90 Cash FlowN/A Price / Cash FlowN/A Book Value$2.04 per share Price / Book0.33Miscellaneous Outstanding Shares6,593,000Free Float6,527,000Market Cap$4.47 million OptionableNot Optionable Beta2.06 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (NASDAQ:CELZ) was last updated on 10/29/2026 by MarketBeat.com Staff. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredTrump’s $16 Trillion Chess Move (signed and highlighted)A newly signed executive order could point to one of the largest resource deals in history, according to Matt ...Monument Traders Alliance | SponsoredDO YOU LIVE HERE? ⬇️Data centers now number about 1,300 across the US, with another 2,500 planned. Each can draw as much power as ...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
